Malaguarnera, M., Vacante, M., Motta, M., Malaguarnera, M., Li, Volti G., and Galvano, F
Its important to note that there is no standardized GLP-1 microdosing chart or microdosing schedule that applies to everyone
10.1007/s40262-018-0655-4 115
According to the subgroup analysis, patients with diabetic neuropathic pain appeared to have a better response from ALC compared with those due to a non-diabetic cause, which is consistent with recent systematic reviews [26,27]
However, they work through different mechanisms and can complement each other when used thoughtfully